NEWS
OKLAHOMA CITY – The prestigious Harold Hamm International Prize for Biomedical Research in Diabetes, an honor bestowed by OU Health Harold Hamm Diabetes Center at the University of Oklahoma Health Sciences, will be awarded this fall to Professor Dr. Anette-Gabriele Ziegler, Director of the Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health. She is also Chair in Diabetes and Gestational Diabetes at Technische Universität München, School of Medicine. She is being honored for her research to understand the pathogenesis of Type 1 diabetes and efforts toward its prediction, early diagnosis and prevention.
The Hamm Prize recognizes and encourages lasting advances in research related to Type 1 or Type 2 diabetes. It is awarded to an individual who has either demonstrated lifelong contributions to the field or realized a singular advance, especially one that promotes curative potential. The honor includes a $250,000 award, the largest of its kind in the world. It was established to recognize and promote lasting achievements in diabetes research focused on progress toward a cure.
“The award is an incredible motivation to look ahead and continue on the path toward understanding the pathogenesis of Type 1 diabetes and developing preventive therapies – with the ultimate goal of finding a cure,” Ziegler said.
The prize, established in 2012, is named for Harold Hamm, chairman and chief executive officer of Oklahoma-based Continental Resources Inc., who provided an endowment to fund the prize in perpetuity. The Hamm Prize laureate is selected by a rotating jury of national and international leaders in the diabetes research community and is awarded every two years.
“This prize honors work that changes the course of science – and Dr. Ziegler’s research does exactly that. Her leadership in uncovering how Type 1 diabetes begins and how we might stop it before it starts is the kind of bold, life-changing progress this prize was meant to recognize. Her work fuels our hope – and brings us all one step closer to the cure,” Hamm said.
Ziegler’s research has been at the forefront of translating important research questions into longitudinal studies, including more than 20 clinical trials, as well as implementing findings into public health. Her achievements include:
In addition, Ziegler has made the following research discoveries:
A physician who conducts research, Ziegler said caring for patients has informed her career as a scientist.
“My mentor always used to say, ‘A researcher is the best doctor,’” she said. “I’m not sure if the reverse is true, but my daily work with people living with diabetes and my experience as a physician have certainly shaped my research. They have especially influenced my strong focus on translational research, clinical trials, and investigating the origins of the disease in humans.”
Ziegler will receive the Hamm Prize during a gala in October. Jed Friedman, Ph.D., director of Harold Hamm Diabetes Center and professor in the OU College of Medicine, said Ziegler’s distinguished research career has significantly advanced the aim of preventing Type 1 diabetes.
“Professor Dr. Ziegler’s visionary leadership and unwavering commitment have not only advanced scientific understanding but also paved the way for novel interventions that improve patient outcomes by delaying the onset of Type 1 diabetes,” Friedman said. “Her work exemplifies the integration of rigorous research with compassionate clinical application, embodying the highest ideals of medical science. We are privileged to honor [her] for her unparalleled contributions to diabetes research and her enduring impact on public health.”
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university with campuses in Norman, Oklahoma City and Tulsa. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. In Oklahoma City, OU Health Sciences is one of the nation’s few academic health centers with seven health profession colleges located on the same campus. OU Health Sciences serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs spanning Oklahoma City and Tulsa and is the leading research institution in Oklahoma. For more information about OU Health Sciences, visit www.ouhsc.edu.
Three University of Oklahoma graduate students have been named winners of the 2025 Three Minute Thesis competition, which challenges participants to explain their research in three minutes to a non-specialist audience.
Sarah Sharif, a researcher with the University of Oklahoma, has been awarded funding from the U.S. Department of Defense (DoD) to create innovative light detectors that pick up mid-wave and long-wave infrared signals at higher temperatures than previously considered achievable.
A team from OU and WVU recently earned a five-year, $3.5 million grant from the National Institutes of Health to study how concept cigarillos influence the potential for addiction. The results will be used to inform the FDA’s impending flavor ban on cigar products and could have wider-reaching implications for other tobacco products that come in flavors, such as e-cigarettes and tobacco-free nicotine pouches.
